MedTrace Logo

Supplementary Angiographic Embolization for Peptic Ulcer Bleeding

NCT01125852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2013-05-14

No results posted yet for this study

Summary

Peptic ulcer bleeding is a common disorder. Despite optimal endoscopic and medical treatment, there is a high risk of rebleeding and high mortality. In this study the investigators examine whether combined endoscopic haemostasis and angiographic embolization resolves in a better outcome than the traditional use of endoscopic haemostasis alone. The study is a randomised controlled trail.

Conditions

  • Peptic Ulcer Hemorrhage

Interventions

PROCEDURE

Angiographic embolization

Patients in the intervention arm receive supplementary angiographic embolization within 24 hours from the therapeutic endoscopy.

PROCEDURE

Therapeutic endoscopy

Patients are treated with standard therapeutic upper endoscopy including endoscopic combination therapy.

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01125852 on ClinicalTrials.gov